|
Blockmir Technology to Selectively Up Regulate Therapeutic Targets and Neutralise Disease-Associated microRNA Activity
Overview
Mirrx Therapeutics A/S is commercializing innovative ”Blockmir” oligonucleotide technology, a proprietary therapeutic paradigm with potential to (i) enhance the protein expression of previously undruggable targets, and (ii) neutralise pathological microRNA expression via selective blockade of microRNA-based gene regulation.
Blockmir
Blockmir...
Published: 10/8/2024
|
Inventor(s): David Bauer, Melissa Acosta
Keywords(s): Biomaterials, Technologies, Therapeutics
Category(s): Technology Classifications > Therapeutics, Agriculture > Abandoned Material, Technology Classifications > Diagnostics
|